Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia

MLA

Ribera, Josep-Maria, et al. “Chemotherapy or Allogeneic Transplantation in High-Risk Philadelphia Chromosome–negative Adult Lymphoblastic Leukemia.” Blood, vol. 137, no. 14, Apr. 2021, pp. 1879–94. EBSCOhost, https://doi.org/10.1182/blood.2020007311.

APA

Ribera, J.-M., Morgades, M., Ciudad, J., Montesinos, P., Esteve, J., Genescà, E., Barba, P., Ribera, J., García-Cadenas, I., Moreno, M. J., Martínez-Carballeira, D., Torrent, A., Martínez-Sánchez, P., Monsalvo, S., Gil, C., Tormo, M., Artola, M. T., Cervera, M., González-Campos, J., … Orfao, A. (2021). Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia. Blood, 137(14), 1879–1894. https://doi.org/10.1182/blood.2020007311

Chicago

Ribera, Josep-Maria, Mireia Morgades, Juana Ciudad, Pau Montesinos, Jordi Esteve, Eulàlia Genescà, Pere Barba, et al. 2021. “Chemotherapy or Allogeneic Transplantation in High-Risk Philadelphia Chromosome–negative Adult Lymphoblastic Leukemia.” Blood 137 (14): 1879–94. doi:10.1182/blood.2020007311.